XML 26 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions (Tables)
9 Months Ended
Sep. 30, 2016
Related Party Transactions [Abstract]  
Summary of milestone payments

Milestones Payments 
    
(1) filing of an New Drug Application (“NDA”) or regulatory approval for each licensed product $750,000 
(2) upon the receipt of regulatory approval from the U.S. FDA for each licensed product  1,750,000